AMOTL1 and cervical carcinoma: In cervical cancer, Wan et al. reported that miR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 [32], and Zhang et al. showed that miR-124 inhibits the proliferation, invasion, migration and epithelial-mesenchymal transition of cervical cancer [33].